Literature DB >> 16616034

Effect of acute cocaine administration on the QTc interval of habitual users.

Anthony R Magnano1, Naresh B Talathoti, Ravindra Hallur, Derek T Jurus, Jose Dizon, Steve Holleran, Daniel M Bloomfield, Eric Collins, Hasan Garan.   

Abstract

The proarrhythmic effects of cocaine may be mediated in part by its effects on cardiac repolarization properties. This study evaluated the acute effects of smoking cocaine 25 mg on the electrocardiograms of 14 habitual cocaine users during a 12-minute observation period. After cocaine administration, heart rate increased by a mean of 22 beats/min (p <0.0001). One patient developed accelerated junctional rhythm, and 5 had nonspecific ST-T-wave abnormalities. The electrocardiograms revealed significant prolongation of the QTc interval (p <0.001) after cocaine administration. In addition, T-wave amplitude decreased and U-wave amplitude increased in response to cocaine use (p <0.05). QRS duration was unchanged by cocaine, whereas the PR interval shortened slightly. The repolarization changes observed after cocaine use were similar to those reported for other sympathomimetic agents and may be a contributing factor in the association between cocaine use and ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616034     DOI: 10.1016/j.amjcard.2005.11.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.

Authors:  David W Abramson; Davin K Quinn; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation.

Authors:  Stella C Wong; James R Roberts
Journal:  J Med Toxicol       Date:  2007-12

Review 3.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

4.  Domain Adaptation Methods for Improving Lab-to-field Generalization of Cocaine Detection using Wearable ECG.

Authors:  Annamalai Natarajan; Gustavo Angarita; Edward Gaiser; Robert Malison; Deepak Ganesan; Benjamin M Marlin
Journal:  Proc ACM Int Conf Ubiquitous Comput       Date:  2016-09

Review 5.  Vascular disease in cocaine addiction.

Authors:  Keren Bachi; Venkatesh Mani; Devi Jeyachandran; Zahi A Fayad; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Atherosclerosis       Date:  2017-03-14       Impact factor: 5.162

6.  Conditional Random Fields for Morphological Analysis of Wireless ECG Signals.

Authors:  Annamalai Natarajan; Edward Gaiser; Gustavo Angarita; Robert Malison; Deepak Ganesan; Benjamin Marlin
Journal:  ACM BCB       Date:  2014

7.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

8.  Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats.

Authors:  Susan K Wood; Diwahar Narasimhan; Ziva Cooper; Roger K Sunahara; James H Woods
Journal:  Drug Alcohol Depend       Date:  2009-10-01       Impact factor: 4.492

9.  A Rare Case of Second Degree Mobitz Type II AV Block Associated with Cocaine Use.

Authors:  Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Mohammed Al-Sadawi; Rodaina Ahmed; Jason Green; Iya Dubson; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-08-21

10.  Cocaine Hydrolase Gene Transfer Demonstrates Cardiac Safety and Efficacy against Cocaine-Induced QT Prolongation in Mice.

Authors:  Vishakantha Murthy; Santiago Reyes; Liyi Geng; Yang Gao; Stephen Brimijoin
Journal:  J Pharmacol Exp Ther       Date:  2015-12-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.